Abstract
The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.
| Original language | English |
|---|---|
| Pages (from-to) | 477-493 |
| Number of pages | 17 |
| Journal | Clinics in Liver Disease |
| Volume | 14 |
| Issue number | 3 |
| DOIs | |
| State | Published - Aug 1 2010 |
Fingerprint
Keywords
- Antiviral therapy
- Cirrhosis
- End-stage liver disease
- Hepatitis B
- Liver transplantation
ASJC Scopus subject areas
- Hepatology
Cite this
Management of end-stage liver disease in chronic hepatitis B. / Tan, Hui Hui; Martin, Paul.
In: Clinics in Liver Disease, Vol. 14, No. 3, 01.08.2010, p. 477-493.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Management of end-stage liver disease in chronic hepatitis B
AU - Tan, Hui Hui
AU - Martin, Paul
PY - 2010/8/1
Y1 - 2010/8/1
N2 - The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.
AB - The consequences of chronic hepatitis B virus infection include hepatocellular carcinoma and liver cirrhosis. Effective antiviral therapy in patients with hepatitis B with advanced liver disease with viral suppression and sustained HBeAg seroconversion (where applicable) may abort hepatic decompensation, diminish hepatocellular risk, and reduce the risk of viral recurrence after transplantation. Overt hepatic decompensation is an indication for referral to a transplant center.
KW - Antiviral therapy
KW - Cirrhosis
KW - End-stage liver disease
KW - Hepatitis B
KW - Liver transplantation
UR - http://www.scopus.com/inward/record.url?scp=77954632240&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954632240&partnerID=8YFLogxK
U2 - 10.1016/j.cld.2010.05.006
DO - 10.1016/j.cld.2010.05.006
M3 - Article
C2 - 20638026
AN - SCOPUS:77954632240
VL - 14
SP - 477
EP - 493
JO - Clinics in Liver Disease
JF - Clinics in Liver Disease
SN - 1089-3261
IS - 3
ER -